Gene therapy for retinal dystrophies: twenty years in the making. (2012)
Attributed to:
Development of an AAV vector for treatment of inherited retinal dystrophy caused by RPE65 deficiency
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1089/hum.2012.2506
PubMed Identifier: 22490129
Publication URI: http://europepmc.org/abstract/MED/22490129
Type: Journal Article/Review
Volume: 23
Parent Publication: Human gene therapy
Issue: 4
ISSN: 1043-0342